CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

The FDA was all in on AI. Will that change?

RegulatoryNegative
AI Analysis

Summary

The FDA's agency-wide AI strategy faces uncertainty due to high-level staff turnover, potentially affecting the pace of AI adoption at the regulatory agency.

Importance:3/10
Sentiment:
-0.30
FDAAIregulatory strategyorganizational change

Read the original article

Published by BioPharma Dive on July 28, 2026 12:00 PM

Read Original